Skip to main content
Equibles

Nathan Trebek

Analyst

Wells Fargo

Equibles does not estimate personal net worth.

About Nathan Trebek

Nathan Trebek is recorded as Analyst at Wells Fargo. Nathan Trebek has spoken on 4 earnings calls across 4 companies, most recently for PROCEPT BioRobotics Corp on November 4, 2026. Those appearances were for PROCEPT BioRobotics Corp (PRCT), Heartflow, Inc. (HTFL), iRhythm Holdings, Inc. (IRTC) and Integer Holdings Corp (ITGR). The companies whose calls Nathan Trebek spoke on are classified in the Healthcare sector.

Nathan Trebek on recent calls

“Larry, just at a high level, can you just touch on some of the key priorities for you for next year?”
Analyst — Wells Fargo, Q3 2026 Procept BioRobotics Earnings Conference Call ·
“Can you talk about the utilization that you're seeing for plaque analysis in your FFRCT accounts?”
Analyst — Wells Fargo, Heartflow, Inc. Q4 FY2025 Earnings Call ·
“Just to kick it off, Q3 growth accelerated versus the first half and guidance implies over 20% in Q4. You didn't see the expected seasonal step down. So, you know, your core zeal monitor business has been accelerating for the past couple of quarters on record new account openings.”
Analyst — Wells Fargo, iRhythm Holdings, Inc. Q3 FY2025 Earnings Call ·
“You know, can you just give color on, so these two ET products and the Nuremont product, how long were they in the market? I'm trying to understand, was there an inventory build in 2025 that contributed to the sales growth and then the end market demand is just not panning out?”
Analyst — Wells Fargo, Integer Holdings Corp Q3 FY2025 Earnings Call ·

Affiliation history

  • Wells Fargo

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity